This example shows a sample report table, trial design, and results dataset for study 123 for the determination of the in vitro genotoxicity potential of tobacco products using the in vitro micronucleus assay. TOBA-642
-
Getting issue details...STATUS
Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records,TOBA-366UNDER GGG REVIEWsince both GLP types apply for this study.
Row 3:
Shows that this study was conducted as a GLP study.
Rows 4-5:
Show the study start date and study title.
Rows 6-7:
Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:
Shows the applicant's organization.
Row 9:
Shows that the applicant's study reference ID is not applicable.
Rows 10-13:
Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID=1). The study director is associated with the test facility.
Rows 14-16:
Show that TSGRPID (TSGRPID=4) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER). TOBA-56-Assay StandardDONE
Row 17:
Shows the study type for this study.
Row 18:
Shows that this study includes a Mammalian Cell Micronucleus Assay.
Rows 19-27:
Show that TSGRPID (TSGRPID = 2) has been used to link the information for 1 species (salmonella) with the 4 different strains and cell lines that are tested in this study.
Rows 28-30:
Show that TSGRPID (TSGRPID = 3) has been used to link the information for 1 species (E. coli) with the strain and cell line that is tested in this study.TOBA-665UNDER G
Rows 1-2:
Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP types apply for this example study.
Row 3:
Shows that this study was conducted as a GLP study.
Rows 4-5:
Show the study start date and study title.
Rows 6-7:
Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:
Shows the applicant's organization.
Row 9:
Shows that the applicant's study reference ID is not applicable.
Rows 10-13:
Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The study director is associated with the test facility.
Rows 14-16:
Show that TSGRPID (TSGRPID=2) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER). TOBA-56
- Jira project doesn't exist or you don't have permission to view it.
Row 17:
Shows the study type for this study.
Row 18:
Shows that this study includes a Mammalian Cell Micronucleus Assay.
Rows 19-20:
Show that the species is human and the cell line is TK6 lymphoblastoid in this study.
ts.xpt
xx.xpt
Row
STUDYID
DOMAIN
TSSEQ
TSGRPID
TSPARMCD
TSPARM
TSVAL
TSVALNF
1
123
TS
1
GLPTYP
Good Laboratory Practice Type
FDA
2
123
TS
2
GLPTYP
Good Laboratory Practice Type
OECD
3
123
TS
1
GLPFL
GLP Flag
Y
4
123
TS
1
STSTDTC
Study Start Date
2022-05-25
5
123
TS
1
STITLE
Study Title
Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay
6
123
TS
1
SNDIGVER
SEND Implementation Guide Version
TOBACCO IMPLEMENTATION GUIDE VERSION 1.0
7
123
TS
1
SNDCTVER
SEND Controlled Terminology Version
SEND Terminology 2021-09-30
8
123
TS
1
APPLCNT
Applicant OrganizationTOBA-356
- Jira project doesn't exist or you don't have permission to view it.
Example Applicant, Inc.
9
123
TS
1
APREFID
Study Reference ID
NOT APPLICABLE
10
123
TS
1
1
TSTFNAM
Test Facility Name
Example Test Lab Name
11
123
TS
1
1
TSTFLOC
Test Facility Location
10 Somewhere Street, Montgomery, AL 10000
12
123
TS
1
1
TFCNTRY
Test Facility Country
USA
13
123
TS
1
1
STDIR
Study Director
Dr. R. Smith
14
123
TS
1
2
TSTGDNAM
Testing Guideline Name
GUIDELINE FOR THE TESTING OF CHEMICALS No. 487
15
123
TS
1
2
TSTGDORG
Testing Guideline Organization
OECD
16
123
TS
1
2
TSTGDVER
Testing Guideline Version
29-July-2016
17
123
TS
1
SSTYP
Study Type
GENOTOXICITY IN VITRO
18
123
TS
1
GNTXAID
Genetic Toxicology Assay Identifier
MNvit
19
123
TS
1
SPECIES
Species
HUMAN
20
123
TS
1
CELLLN
Cell Line
TK6 LYMPHOBLASTOID
Dataset Debug Messages
When the JIRA issue(s) present in the dataset have been resolved, and their resolution has been confirmed by governance, please remove them.
This example Trial Sets dataset shows information about the test conditions for set A1 and A2 in this example study. Sets A1 and A2 can be seen in the first and second rows respectively of the sample report Table 1 (above). For brevity, the TX dataset and the findings (GT) dataset do not show information for any other sets. Fully formed datasets for this example study would include information about the test conditions and findings for all sets. TOBA-457
-
Getting issue details...STATUS
Rows 1-17:
Show the experimental parameters that are common for table 1 of study 123.
Rows 18, 25:
Show that sets A1 and A2 each have a parent set code of A. As a child of set A, each of these sets inherit the test conditions of set A.
Rows 18-24:
Show trial set parameters and values that comprise the test conditions for trial set A1. Set A1 is the data for the negative control (concentration 0) with short-term exposure and metabolic activation S9. The applicant has chosen to given a long name (SET) equal to "ST+S9_C0".
Set A1 is associated with the first row in the sample report table for study 123.
Rows 25-31:
Show trial set parameters and values that comprise the test conditions for trial set A2. Set A2 is the data for the short-term exposure with metabolic activation S9 at a concentration of 1250 ug/ml. The applicant has chosen to give the set a long name (SET) equal to "ST+S9_C1250".
Set A2 is associated with the second row in the sample report table for study 123.
tx.xpt
tx.xpt
Row
STUDYID
DOMAIN
SETCD
SET
TXSEQ
TXPARMCD
TXPARM
TXVAL
1
123
TX
A
ST+S9
1
METACTIND
Metabolic Activating Agent Name
+S9
2
123
TX
A
ST+S9
2
METACTFL
Presence of Metabolic Activation Flag
Y
3
123
TX
A
ST+S9
3
IVTDMIN
In vitro Treatment Duration Minimum
3
4
123
TX
A
ST+S9
4
IVTDTRG
In vitro Treatment Duration Target
3.5
5
123
TX
A
ST+S9
5
IVTDMAX
In vitro Treatment Duration Maximum
4
6
123
TX
A
ST+S9
6
IVTDU
In vitro Treatment Duration Unit
HOURS
7
123
TX
A
ST+S9
7
RCVDMIN
Recovery Duration Minimum
23.5
8
123
TX
A
ST+S9
8
RCVDTRG
Recovery Duration Target
24
9
123
TX
A
ST+S9
9
RCVDMAX
Recovery Duration Maximum
24.5
10
123
TX
A
ST+S9
10
RCVDU
Recovery Duration Unit
HOURS
11
123
TX
A
ST+S9
11
INCBTMP
Incubation Temperature
37
12
123
TX
A
ST+S9
12
INCBTMPU
Incubation Temperature Unit
C
13
123
TX
A
ST+S9
13
ATMRHP
Atmospheric Relative Humidity Percent
50
14
123
TX
A
ST+S9
14
ATMCO2P
Atmospheric CO2 Percent
5
15
123
TX
A
ST+S9
15
SPTOBID
Applicant-defined tobacco identifier
CIG01a
16
123
TX
A
ST+S9
16
EXPTYP
Exposure Type
Submerged
17
123
TX
A
ST+S9
17
SAMTYP
Sample Type
Total Particulate Matter in DMSO
18
123
TX
A1
ST+S9_C0
1
PSETCD
Parent Set Code
A
19
123
TX
A1
ST+S9_CO
2
ITVNAM
Intervention Article Name
Tobacco ProdA
20
123
TX
A1
ST+S9_C0
3
ITVTYPE
Intervention Article Type
Negative Control
21
123
TX
A1
ST+S9_C0
4
ITVCONC
Intervention Article Concentration
0
22
123
TX
A1
ST+S9_C0
5
ITVCONCU
Intervention Article Concentration Unit
ug/ml
23
123
TX
A1
ST+S9_C0
6
SPDEVID
Applicant-defined device identifier
PUFFMASTER3K
24
123
TX
A1
ST+S9_C0
7
SMKRGM
Smoking Regimen
MEDIUM INTENSITY REGIMEN
25
123
TX
A2
ST+S9_C1250
1
PSETCD
Parent Set Code
A
26
123
TX
A2
ST+S9_C1250
2
ITVNAM
Intervention Article Name
Tobacco ProdA
27
123
TX
A2
ST+S9_C1250
3
ITVTYPE
Intervention Article Type
Product
28
123
TX
A2
ST+S9_C1250
4
ITVCONC
Intervention Article Concentration
1250
29
123
TX
A2
ST+S9_C1250
5
ITVCONCU
Intervention Article Concentration Unit
ug/ml
30
123
TX
A2
ST+S9_C1250
6
SPDEVID
Applicant-defined Device Identifier
PUFFMASTER2023
31
123
TX
A2
ST+S9_C1250
7
SMKRGM
Smoking Regimen
HIGH INTENSITY REGIMEN
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Row 1:
Shows the value of REFID=C0. This REFID refers to the trial set with a SETCD of "A1", as defined in the TX dataset. LEVEL=1 and LVLDESC="EXPERIMENTAL UNIT/TRIAL SET" indicates this identifier is referring to both the experimental unit and the unit to which the treatment is applied, and to the entire trial set.
Rows 2-5:
Show the values of 4 observational units (C0_Count1 through C0_Count4) that are within the parent experimental unit, REFID=C0. In this example assay, these observational units are also all within the same trial set, as defined in the TX dataset.
Row 6:
Shows the value of REFID=C1250. This REFID refers to the trial set with a SETCD of "A2", as defined in the TX dataset. LEVEL=1 and LVLDESC="EXPERIMENTAL UNIT/TRIAL SET" indicates this identifier is referring to both the experimental unit and the unit to which the treatment is applied, and to the entire trial set.
Rows 7-10:
Show the values of 4 observational units (C1250_Count1 through C1250_Count4) TOBA-687
- Jira project doesn't exist or you don't have permission to view it.
that are within the parent experimental unit, REFID=C1250. In this example assay, these observational units are also all within the same trial set, as defined in the TX dataset.
$titleHtml
relref.xpt
Row
STUDYID
SETCD
REFID
PARENT
LEVEL
LVLDESC
1
123
A1
C0
1
EXPERIMENTAL UNIT/TRIAL SET
2
123
A1
C0-Count1
C0
2
OBSERVATIONAL UNIT
3
123
A1
C0-Count2
C0
2
OBSERVATIONAL UNIT
4
123
A1
C0-Count3
C0
2
OBSERVATIONAL UNIT
5
123
A1
C0-Count4
C0
2
OBSERVATIONAL UNIT
6
123
A2
C1250
1
EXPERIMENTAL UNIT/TRIAL SET
7
123
A2
C1250-Count1
C1250
2
OBSERVATIONAL UNIT
8
123
A2
C1250-Count2
C1250
2
OBSERVATIONAL UNIT
9
123
A2
C1250-Count3
C1250
2
OBSERVATIONAL UNIT
10
123
A2
C1250-Count4
C1250
2
OBSERVATIONAL UNIT
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Rows 1-3, 8:
Show percentage result values that apply to GTREFID=C0. REFID=C0, as shown in the RELREF dataset, relates this data to the trial set in the first row of table 1 in the sample report table for study 123.
Rows 4-7:
Show the 4 micronucleated cell counts for the observational units with GTREFID from C0-Count1 through C0-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.
Rows 9-11, 16:
Show percentage result values that apply to GTREFID=C1250. REFID=C1250, as shown in the RELREF dataset, relates this data to the trial set in the second row of table 1 in the sample report table for study 123.
Rows 12-15:
Show the 4 micronucleated cell counts for the observational units with GTREFID from C1250-Count1 through C1250-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.
gt.xpt
gt.xpt
Row
STUDYID
DOMAIN
GTREFID
GTSEQ
GTTESTCD
GTTEST
GTCELLEV
GTORRES
GTORRESU
GTCOLSRT
GTSTRESC
GTSTRESN
GTSTRESU
GTDTC
1
123
GT
C0
1
RICCTOBA-643
- Jira project doesn't exist or you don't have permission to view it.
Relative Increase in Cell Count
154
0
%
0
0
%
2022-05-25
2
123
GT
C0
2
RCC
Relative Cell Count
154
0
%
0
0
%
2022-05-25
3
123
GT
C0
3
RPD
Relative Population Doubling
154
0
%
0
0
%
2022-05-25
4
123
GT
C0-Count1
4
MNCE
Micronucleated Cells
2205
15
Cells
15
15
Cells
2022-05-25
5
123
GT
C0-Count2
5
MNCE
Micronucleated Cells
2474
13
Cells
13
13
Cells
2022-05-25
6
123
GT
C0-Count3
6
MNCE
Micronucleated Cells
2758
17
Cells
17
17
Cells
2022-05-25
7
123
GT
C0-Count4
7
MNCE
Micronucleated Cells
2669
12
Cells
12
12
Cells
2022-05-25
8
123
GT
C0
8
MNCECE
Micronucleated Cells/Total Cells
0.57
%
0.57
0.57
%
2022-05-25
9
123
GT
C1250
1
RICC
Relative Increase in Cell Count
134
15.7
%
15.7
15.7
%
2022-05-25
10
123
GT
C1250
2
RCC
Relative Cell Count
134
13.0
%
13.0
13.0
%
2022-05-25
11
123
GT
C1250
3
RPD
Relative Population Doubling
134
7.9
%
7.9
7.9
%
2022-05-25
12
123
GT
C1250-Count1
4
MNCE
Micronucleated Cells
3266
20
Cells
20
20
Cells
2022-05-25
13
123
GT
C1250-Count2
5
MNCE
Micronucleated Cells
2190
17
Cells
17
17
Cells
2022-05-25
14
123
GT
C1250-Count3
6
MNCE
Micronucleated Cells
2758
13
Cells
13
13
Cells
2022-05-25
15
123
GT
C1250-Count4
7
MNCE
Micronucleated Cells
2714
21
Cells
21
21
Cells
2022-05-25
16
123
GT
C1250
8
MNCECE
Micronucleated Cells/Total Cells
0.66
%
0.66
0.66
%
2022-05-25
Dataset Debug Message
When the JIRA issue(s) present in the dataset have been resolved, and their resolution has been confirmed by governance, please remove them.
